ONYX PHARMACEUTICALS INC: cashflow_operating
| Value | {"amount": -86977000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-06-30 |
| Status | superseded |
| Entity | ONYX PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:49:46.140887+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/59b03484-f07a-4a14-91cd-e17e5f37c1a4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-337971 · Open the official SEC filing →Retrieved: 2026-08-19T09:49:46.140887+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001012140/cashflow-operating/2012-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/59b03484-f07a-4a14-91cd-e17e5f37c1a4
History
- no predecessors — first report